Privia Health Group, Inc. (NASDAQ: PRVA) reported Q2 EPS of $0.17, $0.08 better than the analyst estimate of $0.09. Revenue for the quarter came in at $413.4 million versus the consensus estimate of $392.06 million.

For earnings history and earnings-related data on Privia Health Group, Inc. (PRVA) click here.